DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by James, M. O.
Right arrow Articles by Stacpoole, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, M. O.
Right arrow Articles by Stacpoole, P. W.

Vol. 26, Issue 11, 1134-1143, November 1998

Pharmacokinetics and Metabolism of [14C]Dichloroacetate in Male Sprague-Dawley Rats
Identification of Glycine Conjugates, Including Hippurate, as Urinary Metabolites of Dichloroacetate

Margaret O. James, Zimeng Yan,1 Rachel Cornett, V. Murali K. M. Jayanti,2 George N. Henderson, Natalia Davydova, Michael J. Katovich, Brad Pollock, and Peter W. Stacpoole

Departments of Medicinal Chemistry (MOJ, RC, VMKMJ) and Pharmacodynamics (MJK), College of Pharmacy, and Department of Medicine, Division of Endocrinology and Metabolism (ZY, GNH, ND, PWS), Department of Health Policy and Epidemiology (BP), and Department of Biochemistry and Molecular Biology (PWS), College of Medicine, University of Florida

Pathways of metabolism of dichloroacetate (DCA), an investigational drug for the treatment of lactic acidosis in humans and a rodent hepatocarcinogen, are poorly understood. In this study, rats were given, by gavage, one or two 50 mg/kg doses of NaDCA. DCA labeled with 14C (carboxy carbon) or 13C (both carbons) was used in studies of disposition and pharmacokinetics, respectively. The effect of fasting for 14 hr before dosing was studied. Expired air, urine, feces, and tissues were collected from [14C]DCA-dosed rats. Urine was analyzed by HPLC, GC/MS, and NMR spectroscopy. Plasma samples were analyzed by GC/MS. DCA plasma elimination half-lives were 0.1 ± 0.02 and 5.4 ± 0.8 hr in young adult rats (180-265 g, 3-4 months of age) given one or two doses of DCA, respectively, and 9.7 ± 1 hr in large, 16-month-old rats given two DCA doses. The percentage of the DCA dose excreted as CO2 varied from 17 to 46% and was lower (p < 0.001) in fed rats, compared with rats fasted overnight before dosing. Urine contained DCA and DCA metabolites, including oxalate, glyoxylate, and conjugated glycine (mainly hippurate and phenylacetylglycine). More unchanged DCA was excreted by large rats pretreated with DCA (mean, 20.2% of the dose) than by young adult rats given one dose of DCA (mean, 0.5%). This study confirmed that CO2, glycine, and oxalate are major products of DCA metabolism, it demonstrated that one dose of DCA altered the elimination of a subsequent dose, and it showed that age or body size, as well as access to food, significantly affected DCA metabolism in rats.


1   Present address: American Cyanamid, Princeton, NJ.
2   Present address: Abbott Pharmaceuticals, Chicago, IL.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. L. Shroads, X. Guo, V. Dixit, H.-P. Liu, M. O. James, and P. W. Stacpoole
Age-Dependent Kinetics and Metabolism of Dichloroacetate: Possible Relevance to Toxicity
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1163 - 1171.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. Jia, B. Coats, M. Chadha, B. Frentzen, J. Perez-Rodriguez, P. A. Chadik, R. A. Yost, G. N. Henderson, and P. W. Stacpoole
Human Kinetics of Orally and Intravenously Administered Low-Dose 1,2-13C-Dichloroacetate.
J. Clin. Pharmacol., December 1, 2006; 46(12): 1449 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
X. Guo, V. Dixit, H. Liu, A. L. Shroads, G. N. Henderson, M. O. James, and P. W. Stacpoole
INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
Drug Metab. Dispos., January 1, 2006; 34(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. B. M. Lantum, R. B. Baggs, D. M. Krenitsky, and M. W. Anders
Nephrotoxicity of Chlorofluoroacetic Acid in Rats
Toxicol. Sci., December 1, 2002; 70(2): 261 - 268.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.